Molecular Therapy -- Nucleic Acids - Table of Contents alert Volume 2 Issue 9, September 2013

TABLE OF CONTENTS Volume 2, September 2013 In this issue Methods - Original Article Original Articles Advertisement Don't miss out! Check out the latest Editor's picks articles from Molecular Therapy Nucleic Acids: - Preclinical In Vivo Evaluation of the Safety of a Multi-shRNA-based Gene Therapy Against HIV-1 (Open)  - Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide Modifier. (Open)    Methods - Original Article Top Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34+ Cells Correlates With In Vivo Vector Copy Number Naoya Uchida, Molly E Evans, Matthew M Hsieh, Aylin C Bonifacino, Allen E Krouse, Mark E Metzger, Stephanie E Sellers, Cynthia E Dunbar, Robert E Donahue and John F Tisdale Mol Ther Nucleic Acids 2013 2: e122; 10.1038/mtna.2013.49 Abstract | Full Text Original Articles Top A Potential New Therapeutic Approach for Friedreich Ataxia: Induction of Frataxin Expression With TALE Proteins Pierre Chapdelaine, Zoé Coulombe, Amina Chikh, Catherine Gérard and Jacques P Tremblay Mol Ther Nucleic Acids 2013 2: e119; 10.1038/mtna.2013.41 Abstract | Full Text Minimal-length Synthetic shRNAs Formulated with Lipid Nanoparticles are Potent Inhibitors of Hepatitis C Virus IRES-linked Gene Expression in Mice Anne Dallas, Heini Ilves, Joshua Shorenstein, Adam Judge, Ryan Spitler, Christopher Contag, Suet Ping Wong, Richard P Harbottle, Ian MacLachlan and Brian H Johnston Mol Ther Nucleic Acids 2013 2: e123; 10.1038/mtna.2013.50 Abstract | Full Text Genomic cis-acting Sequences Improve Expression and Establishment of a Nonviral Vector Claudia Hagedorn, Michael N Antoniou and Hans J Lipps Mol Ther Nucleic Acids 2013 2: e118; 10.1038/mtna.2013.47 Abstract | Full Text Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast Cancer Ibrahim Tekedereli, S Neslihan Alpay, Ugur Akar, Erkan Yuca, Cristian Ayugo-Rodriguez, He-Dong Han, Anil K Sood, Gabriel Lopez-Berestein and Bulent Ozpolat Mol Ther Nucleic Acids 2013 2: e121; 10.1038/mtna.2013.45 Abstract | Full Text Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency HaiFang Yin, Prisca Boisguerin, Hong M Moulton, Corinne Betts, Yiqi Seow, Jordan Boutilier, Qingsong Wang, Anthony Walsh, Bernard Lebleu and Matthew JA Wood Mol Ther Nucleic Acids 2013 2: e124; 10.1038/mtna.2013.51 Abstract | Full Text Preclinical In Vivo Evaluation of the Safety of a Multi-shRNA-based Gene Therapy Against HIV-1 Mireille Centlivre, Nicolas Legrand, Sofieke Klamer, Ying Poi Liu, Karin Jasmijn von Eije, Martino Bohne, Esther Siteur-van Rijnstra, Kees Weijer, Bianca Blom, Carlijn Voermans, Hergen Spits and Ben Berkhout Mol Ther Nucleic Acids 2013 2: e120; 10.1038/mtna.2013.48 Abstract | Full Text You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.